$ABBV
AbbVie Inc.

2024 Q3 Form 10-Q Financial Statement

#000155115224000031 Filed on August 07, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2 2023 Q2
Revenue $14.46B $14.46B $13.87B
YoY Change 3.83% 4.31% -4.92%
Cost Of Revenue $4.212B $4.202B $4.192B
YoY Change -35.05% 0.24% 0.53%
Gross Profit $10.25B $10.26B $9.673B
YoY Change 37.7% 6.07% -7.11%
Gross Profit Margin 70.87% 70.94% 69.77%
Selling, General & Admin $4.205B $3.377B $3.174B
YoY Change 24.7% 6.4% -41.35%
% of Gross Profit 41.03% 32.91% 32.81%
Research & Development $2.130B $1.948B $1.728B
YoY Change 23.62% 12.73% 7.4%
% of Gross Profit 20.78% 18.99% 17.86%
Depreciation & Amortization $191.0M $184.0M $190.0M
YoY Change -2.55% -3.16% -6.4%
% of Gross Profit 1.86% 1.79% 1.96%
Operating Expenses $6.335B $5.325B $4.733B
YoY Change 24.34% 12.51% -32.59%
Operating Profit $3.831B $3.998B $4.940B
YoY Change 67.95% -19.07% 49.92%
Interest Expense $720.0M $726.0M -$491.0M
YoY Change 29.73% -247.86% -188.31%
% of Operating Profit 18.79% 18.16% -9.94%
Other Income/Expense, Net -$1.159B -$1.345B -$1.412B
YoY Change -1320.0% -4.75% -7.89%
Pretax Income $2.084B $2.146B $2.610B
YoY Change 6.71% -17.78% 120.63%
Income Tax $520.0M $773.0M $583.0M
% Of Pretax Income 24.95% 36.02% 22.34%
Net Earnings $1.561B $1.370B $2.024B
YoY Change -12.2% -32.31% 119.05%
Net Earnings / Revenue 10.8% 9.47% 14.6%
Basic Earnings Per Share $0.88 $0.77 $1.14
Diluted Earnings Per Share $0.88 $0.77 $1.14
COMMON SHARES
Basic Shares Outstanding 1.766B shares 1.766B shares 1.764B shares
Diluted Shares Outstanding 1.772B shares 1.771B shares 1.771B shares

Balance Sheet

Concept 2024 Q3 2024 Q2 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $7.285B $13.16B $8.766B
YoY Change -45.18% 50.09% -12.0%
Cash & Equivalents $7.257B $13.13B $8.759B
Short-Term Investments $28.00M $27.00M $7.000M
Other Short-Term Assets $4.578B $4.717B $4.540B
YoY Change 0.81% 3.9% 0.75%
Inventory $4.450B $4.218B $4.055B
Prepaid Expenses
Receivables $11.47B $11.72B $11.49B
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $27.79B $33.82B $28.85B
YoY Change -16.37% 17.21% -0.85%
LONG-TERM ASSETS
Property, Plant & Equipment $5.141B $5.023B $4.943B
YoY Change 4.2% 1.62% -0.3%
Goodwill $35.30B $33.39B $32.22B
YoY Change 9.98% 3.61% 0.61%
Intangibles $66.65B $60.24B $62.86B
YoY Change 13.72% -4.17% -12.48%
Long-Term Investments $267.0M $272.0M $288.0M
YoY Change -2.91% -5.56% 18.03%
Other Assets $8.288B $9.197B $6.198B
YoY Change 16.83% 48.39% 23.15%
Total Long-Term Assets $115.6B $108.1B $106.5B
YoY Change 12.27% 1.51% -6.64%
TOTAL ASSETS
Total Short-Term Assets $27.79B $33.82B $28.85B
Total Long-Term Assets $115.6B $108.1B $106.5B
Total Assets $143.4B $141.9B $135.4B
YoY Change 5.29% 4.85% -5.46%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $30.49B $29.33B $27.04B
YoY Change 2.81% 8.48% 19.93%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
Long-Term Debt Due $12.57B $12.59B $5.203B
YoY Change 145.84% 141.9% -56.33%
Total Short-Term Liabilities $43.06B $41.92B $32.24B
YoY Change 23.84% 30.01% -6.48%
LONG-TERM LIABILITIES
Long-Term Debt $58.51B $58.05B $55.81B
YoY Change 5.17% 4.01% -8.51%
Other Long-Term Liabilities $33.03B $32.43B $32.29B
YoY Change 4.38% 0.41% 4.96%
Total Long-Term Liabilities $33.03B $32.43B $32.29B
YoY Change 4.38% 0.41% 4.96%
TOTAL LIABILITIES
Total Short-Term Liabilities $43.06B $41.92B $32.24B
Total Long-Term Liabilities $33.03B $32.43B $32.29B
Total Liabilities $76.09B $74.34B $64.53B
YoY Change 14.57% 15.2% -1.09%
SHAREHOLDERS EQUITY
Retained Earnings -$4.964B -$3.768B $1.789B
YoY Change -632.05% -310.62% -49.12%
Common Stock $21.16B $20.88B $19.84B
YoY Change 5.69% 5.24% 4.93%
Preferred Stock
YoY Change
Treasury Stock (at cost) $7.848B $7.838B $6.528B
YoY Change 20.28% 20.07% 42.19%
Treasury Stock Shares
Shareholders Equity $6.032B $6.778B $12.87B
YoY Change
Total Liabilities & Shareholders Equity $143.4B $141.9B $135.4B
YoY Change 5.29% 4.85% -5.46%

Cashflow Statement

Concept 2024 Q3 2024 Q2 2023 Q2
OPERATING ACTIVITIES
Net Income $1.561B $1.370B $2.024B
YoY Change -12.2% -32.31% 119.05%
Depreciation, Depletion And Amortization $191.0M $184.0M $190.0M
YoY Change -2.55% -3.16% -6.4%
Cash From Operating Activities $5.447B $2.271B $6.319B
YoY Change -28.08% -64.06% 26.25%
INVESTING ACTIVITIES
Capital Expenditures $249.0M $241.0M $178.0M
YoY Change 13.7% 35.39% -224.48%
Acquisitions $0.00
YoY Change
Other Investing Activities -$8.007B -$861.0M -$163.0M
YoY Change 5238.0% 428.22% -159.71%
Cash From Investing Activities -$8.256B -$1.102B -$341.0M
YoY Change 2137.4% 223.17% -362.31%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -3.072B -6.097B -3.920B
YoY Change 15.45% 55.54% 46.32%
NET CHANGE
Cash From Operating Activities 5.447B 2.271B 6.319B
Cash From Investing Activities -8.256B -1.102B -341.0M
Cash From Financing Activities -3.072B -6.097B -3.920B
Net Change In Cash -5.881B -4.928B 2.058B
YoY Change -229.42% -339.46% -16.21%
FREE CASH FLOW
Cash From Operating Activities $5.447B $2.271B $6.319B
Capital Expenditures $249.0M $241.0M $178.0M
Free Cash Flow $5.198B $2.030B $6.141B
YoY Change -29.33% -66.94% 19.29%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q2 us-gaap Impairment Intangible Asset Statement Of Income Or Comprehensive Income Extensible Enumeration
ImpairmentIntangibleAssetStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
CY2024Q2 us-gaap Investment Type Extensible Enumeration
InvestmentTypeExtensibleEnumeration
http://fasb.org/us-gaap/2024#MoneyMarketFundsMember
CY2023Q4 us-gaap Investment Type Extensible Enumeration
InvestmentTypeExtensibleEnumeration
http://fasb.org/us-gaap/2024#MoneyMarketFundsMember
CY2024Q2 us-gaap Collaborative Arrangement Transaction Statement Of Income Or Comprehensive Income Extensible Enumeration
CollaborativeArrangementTransactionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
http://fasb.org/us-gaap/2024#Revenues
us-gaap Collaborative Arrangement Transaction Statement Of Income Or Comprehensive Income Extensible Enumeration
CollaborativeArrangementTransactionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
http://fasb.org/us-gaap/2024#Revenues
us-gaap Collaborative Arrangement Transaction Statement Of Income Or Comprehensive Income Extensible Enumeration
CollaborativeArrangementTransactionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
http://fasb.org/us-gaap/2024#Revenues
CY2023Q2 us-gaap Collaborative Arrangement Transaction Statement Of Income Or Comprehensive Income Extensible Enumeration
CollaborativeArrangementTransactionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
http://fasb.org/us-gaap/2024#Revenues
CY2024Q2 us-gaap Collaborative Arrangement Transaction Statement Of Income Or Comprehensive Income Extensible Enumeration
CollaborativeArrangementTransactionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
http://fasb.org/us-gaap/2024#Revenues
CY2023Q2 us-gaap Collaborative Arrangement Transaction Statement Of Income Or Comprehensive Income Extensible Enumeration
CollaborativeArrangementTransactionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
http://fasb.org/us-gaap/2024#Revenues
us-gaap Collaborative Arrangement Transaction Statement Of Income Or Comprehensive Income Extensible Enumeration
CollaborativeArrangementTransactionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
http://fasb.org/us-gaap/2024#Revenues
us-gaap Collaborative Arrangement Transaction Statement Of Income Or Comprehensive Income Extensible Enumeration
CollaborativeArrangementTransactionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
http://fasb.org/us-gaap/2024#Revenues
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
us-gaap Payments To Acquire Other Investments
PaymentsToAcquireOtherInvestments
1000000000.0 usd
us-gaap Payments To Acquire Other Investments
PaymentsToAcquireOtherInvestments
513000000 usd
CY2024Q2 us-gaap Research And Development Asset Acquired Other Than Through Business Combination Written Off
ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
937000000 usd
CY2023Q2 us-gaap Research And Development Asset Acquired Other Than Through Business Combination Written Off
ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
280000000 usd
us-gaap Research And Development Asset Acquired Other Than Through Business Combination Written Off
ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
1101000000 usd
us-gaap Research And Development Asset Acquired Other Than Through Business Combination Written Off
ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
430000000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
32293000000 usd
us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
1249000000 usd
us-gaap Goodwill Other Increase Decrease
GoodwillOtherIncreaseDecrease
-156000000 usd
CY2024Q2 us-gaap Goodwill
Goodwill
33386000000 usd
CY2024Q2 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
0 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
89812000000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
31149000000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
58663000000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
83333000000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
28026000000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
55307000000 usd
CY2024Q2 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
1580000000 usd
CY2024Q2 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
1580000000 usd
CY2023Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
303000000 usd
CY2023Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
303000000 usd
CY2024Q2 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
91392000000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
31149000000 usd
CY2024Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
60243000000 usd
CY2023Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
83636000000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
28026000000 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
55610000000 usd
CY2024Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1900000000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3800000000 usd
CY2023Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2100000000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
4000000000.0 usd
us-gaap Gain Loss From Components Excluded From Assessment Of Fair Value Hedge Effectiveness Net
GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet
0 usd
us-gaap Gain Loss From Components Excluded From Assessment Of Fair Value Hedge Effectiveness Net
GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet
0 usd
us-gaap Gain Loss From Components Excluded From Assessment Of Cash Flow Hedge Effectiveness Net
GainLossFromComponentsExcludedFromAssessmentOfCashFlowHedgeEffectivenessNet
0 usd
us-gaap Gain Loss From Components Excluded From Assessment Of Cash Flow Hedge Effectiveness Net
GainLossFromComponentsExcludedFromAssessmentOfCashFlowHedgeEffectivenessNet
0 usd
CY2024Q2 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
192000000 usd
CY2023Q4 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
66000000 usd
CY2024Q2 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
341000000 usd
CY2023Q4 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
496000000 usd
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
0 usd
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
0 usd
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3
0 usd
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3
0 usd
CY2023Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
19890000000 usd
CY2022Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
16384000000 usd
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
-2136000000 usd
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
-3424000000 usd
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
876000000 usd
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
657000000 usd
CY2024Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
21150000000 usd
CY2023Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
19151000000 usd
CY2024Q2 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
160000000 usd
CY2023Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
159000000 usd
CY2024Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
218000000 usd
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
179000000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
566000000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
492000000 usd
CY2024Q2 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
34000000 usd
CY2023Q2 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
30000000 usd
us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
94000000 usd
us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
85000000 usd
CY2024Q2 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
184000000 usd
CY2023Q2 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
149000000 usd
us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
472000000 usd
us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
407000000 usd
CY2024Q2 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
3900000000 usd
CY2024Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.36
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.30
CY2023Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.22
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.26
CY2023Q2 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2024Q2 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2024Q2 us-gaap Decrease In Unrecognized Tax Benefits Is Reasonably Possible
DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible
162000000 usd
CY2024Q2 us-gaap Revenues
Revenues
14462000000 usd
CY2023Q2 us-gaap Revenues
Revenues
13865000000 usd
us-gaap Revenues
Revenues
26772000000 usd
us-gaap Revenues
Revenues
26090000000 usd

Files In Submission

Name View Source Status
0001551152-24-000031-index-headers.html Edgar Link pending
0001551152-24-000031-index.html Edgar Link pending
0001551152-24-000031.txt Edgar Link pending
0001551152-24-000031-xbrl.zip Edgar Link pending
abbv-20240630.htm Edgar Link pending
abbv-20240630.xsd Edgar Link pending
abbv-20240630xex311.htm Edgar Link pending
abbv-20240630xex312.htm Edgar Link pending
abbv-20240630xex321.htm Edgar Link pending
abbv-20240630xex322.htm Edgar Link pending
abbv-20240630_g1.jpg Edgar Link pending
abbv-20240630_g2.gif Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
abbv-20240630_def.xml Edgar Link unprocessable
abbv-20240630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
abbv-20240630_htm.xml Edgar Link completed
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
abbv-20240630_cal.xml Edgar Link unprocessable
abbv-20240630_lab.xml Edgar Link unprocessable